OTCMKTS:MEDGF Medacta Group (MEDGF) Stock Price, News & Analysis $83.91 0.00 (0.00%) As of 04/2/2025 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock About Medacta Group Stock (OTCMKTS:MEDGF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medacta Group alerts:Sign Up Key Stats Today's Range$83.91▼$83.9150-Day Range$83.91▼$83.9152-Week Range$83.91▼$86.33VolumeN/AAverage Volume200 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingBuy Company OverviewMedacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine procedures. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.Read More… Remove Ads Receive MEDGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medacta Group and its competitors with MarketBeat's FREE daily newsletter. Email Address MEDGF Stock News HeadlinesMedacta Group SA (VTX:MOVE) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This YearMarch 28, 2025 | finance.yahoo.comMedacta Group price target raised to CHF 146 from CHF 136 at Morgan StanleyMarch 27, 2025 | markets.businessinsider.com[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.April 3, 2025 | Colonial Metals (Ad)Medacta Group SA (XSWX:MOVE) Full Year 2024 Earnings Call Highlights: Record Growth and ...March 26, 2025 | gurufocus.comFull Year 2024 Medacta Group SA Earnings Call TranscriptMarch 26, 2025 | gurufocus.comMedacta Group SA Achieves Robust Growth in 2024 with Innovative Orthopedic SolutionsMarch 25, 2025 | tipranks.comWhy Medacta Group SA (VTX:MOVE) Could Be Worth WatchingMarch 25, 2025 | finance.yahoo.comMedacta Group SA: Medacta Group SA reports an excellent performance in 2024 with an adjusted EBITDA margin1 in constant currency of 28.0%March 25, 2025 | markets.businessinsider.comSee More Headlines MEDGF Stock Analysis - Frequently Asked Questions How have MEDGF shares performed this year? Medacta Group's stock was trading at $83.91 at the start of the year. Since then, MEDGF shares have increased by 0.0% and is now trading at $83.91. View the best growth stocks for 2025 here. How do I buy shares of Medacta Group? Shares of MEDGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today4/03/2025Next Earnings (Estimated)5/07/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:MEDGF CIKN/A Webwww.medacta.com Phone41 91 696 60 60FaxN/AEmployees1,826Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (OTCMKTS:MEDGF) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medacta Group SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Medacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDGF Stock Free MEDGF Stock Alerts